

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.80019484 |
| 2 | cellular ketone body metabolic process (GO:0046950) | 4.37361261 |
| 3 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.03119035 |
| 4 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.00605814 |
| 5 | inositol phosphate dephosphorylation (GO:0046855) | 4.00605814 |
| 6 | ketone body metabolic process (GO:1902224) | 3.95571578 |
| 7 | inositol phosphate catabolic process (GO:0071545) | 3.89441226 |
| 8 | platelet dense granule organization (GO:0060155) | 3.88066633 |
| 9 | response to gravity (GO:0009629) | 3.85569929 |
| 10 | insulin secretion (GO:0030073) | 3.83366013 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 3.76454527 |
| 12 | positive regulation of glycolytic process (GO:0045821) | 3.73610101 |
| 13 | positive regulation of actin filament depolymerization (GO:0030836) | 3.63199116 |
| 14 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.61857291 |
| 15 | inositol phosphate-mediated signaling (GO:0048016) | 3.53461345 |
| 16 | glutamate secretion (GO:0014047) | 3.48332070 |
| 17 | regulation of glucokinase activity (GO:0033131) | 3.43259284 |
| 18 | regulation of hexokinase activity (GO:1903299) | 3.43259284 |
| 19 | neuronal action potential propagation (GO:0019227) | 3.43234694 |
| 20 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.37389726 |
| 21 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.37389726 |
| 22 | endocrine pancreas development (GO:0031018) | 3.33325714 |
| 23 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.32922463 |
| 24 | transferrin transport (GO:0033572) | 3.31380291 |
| 25 | polyol catabolic process (GO:0046174) | 3.30930237 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.23087421 |
| 27 | trivalent inorganic cation transport (GO:0072512) | 3.21640079 |
| 28 | ferric iron transport (GO:0015682) | 3.21640079 |
| 29 | signal peptide processing (GO:0006465) | 3.18718667 |
| 30 | positive regulation of protein autophosphorylation (GO:0031954) | 3.17051941 |
| 31 | xenobiotic catabolic process (GO:0042178) | 3.11638206 |
| 32 | L-phenylalanine metabolic process (GO:0006558) | 3.08380040 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.08380040 |
| 34 | negative regulation of complement activation (GO:0045916) | 2.96505288 |
| 35 | fatty acid elongation (GO:0030497) | 2.95276936 |
| 36 | lactate metabolic process (GO:0006089) | 2.92088299 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.91429123 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 2.91429123 |
| 39 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.90253496 |
| 40 | glycerophospholipid catabolic process (GO:0046475) | 2.87735932 |
| 41 | phagosome maturation (GO:0090382) | 2.87188717 |
| 42 | presynaptic membrane assembly (GO:0097105) | 2.82879320 |
| 43 | macroautophagy (GO:0016236) | 2.82847617 |
| 44 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.82611934 |
| 45 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.81031543 |
| 46 | negative regulation of membrane potential (GO:0045837) | 2.80643155 |
| 47 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.80479131 |
| 48 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.80354320 |
| 49 | tonic smooth muscle contraction (GO:0014820) | 2.79894212 |
| 50 | behavioral response to cocaine (GO:0048148) | 2.78968614 |
| 51 | artery smooth muscle contraction (GO:0014824) | 2.78752081 |
| 52 | peptide hormone processing (GO:0016486) | 2.76330288 |
| 53 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.75634257 |
| 54 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.74178785 |
| 55 | membrane assembly (GO:0071709) | 2.73904355 |
| 56 | nitric oxide mediated signal transduction (GO:0007263) | 2.72611015 |
| 57 | peptide hormone secretion (GO:0030072) | 2.72398509 |
| 58 | magnesium ion transport (GO:0015693) | 2.71632963 |
| 59 | neuron cell-cell adhesion (GO:0007158) | 2.69827956 |
| 60 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.69631863 |
| 61 | peptide secretion (GO:0002790) | 2.69052343 |
| 62 | negative regulation of cation channel activity (GO:2001258) | 2.68869654 |
| 63 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.68470681 |
| 64 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.68470681 |
| 65 | synaptic vesicle maturation (GO:0016188) | 2.67549916 |
| 66 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.67260543 |
| 67 | dopamine transport (GO:0015872) | 2.65741663 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 2.64898956 |
| 69 | zinc ion homeostasis (GO:0055069) | 2.63582584 |
| 70 | positive regulation of insulin secretion (GO:0032024) | 2.63169852 |
| 71 | negative regulation of neurological system process (GO:0031645) | 2.61531181 |
| 72 | regulation of energy homeostasis (GO:2000505) | 2.61430954 |
| 73 | negative regulation of protein activation cascade (GO:2000258) | 2.61199886 |
| 74 | cellular zinc ion homeostasis (GO:0006882) | 2.59903440 |
| 75 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.58388532 |
| 76 | negative regulation of neurotransmitter transport (GO:0051589) | 2.55937496 |
| 77 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.55677737 |
| 78 | positive regulation of neurotransmitter transport (GO:0051590) | 2.53301684 |
| 79 | endosome to pigment granule transport (GO:0043485) | 2.53293290 |
| 80 | endosome to melanosome transport (GO:0035646) | 2.53293290 |
| 81 | neurotransmitter secretion (GO:0007269) | 2.53196762 |
| 82 | vascular smooth muscle contraction (GO:0014829) | 2.52931047 |
| 83 | zinc ion transport (GO:0006829) | 2.52335383 |
| 84 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.51600620 |
| 85 | presynaptic membrane organization (GO:0097090) | 2.51286773 |
| 86 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.51256571 |
| 87 | regulation of metalloenzyme activity (GO:0048552) | 2.51023163 |
| 88 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.50520234 |
| 89 | response to redox state (GO:0051775) | 2.50116608 |
| 90 | peptidyl-cysteine modification (GO:0018198) | 2.49404801 |
| 91 | negative regulation of dendrite development (GO:2000171) | 2.48038063 |
| 92 | zinc ion transmembrane transport (GO:0071577) | 2.46956573 |
| 93 | protein localization to synapse (GO:0035418) | 2.46865078 |
| 94 | proline transport (GO:0015824) | 2.46547031 |
| 95 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.44334810 |
| 96 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.44207133 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.43361804 |
| 98 | neurofilament cytoskeleton organization (GO:0060052) | 2.43027374 |
| 99 | keratinocyte development (GO:0003334) | 2.42840366 |
| 100 | negative regulation of hormone metabolic process (GO:0032351) | 2.42208537 |
| 101 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.41527978 |
| 102 | vocalization behavior (GO:0071625) | 2.41466814 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.40327574 |
| 104 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.40025263 |
| 105 | regulation of vesicle fusion (GO:0031338) | 2.39787951 |
| 106 | hormone secretion (GO:0046879) | 2.39702311 |
| 107 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.39097515 |
| 108 | respiratory chain complex IV assembly (GO:0008535) | 2.38377923 |
| 109 | positive regulation of peptide hormone secretion (GO:0090277) | 2.37531384 |
| 110 | neuron-neuron synaptic transmission (GO:0007270) | 2.37471292 |
| 111 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.37017790 |
| 112 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.37014925 |
| 113 | nitric oxide biosynthetic process (GO:0006809) | 2.36389564 |
| 114 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.36252680 |
| 115 | cellular response to zinc ion (GO:0071294) | 2.35357458 |
| 116 | regulation of cell communication by electrical coupling (GO:0010649) | 2.33886605 |
| 117 | regulation of insulin secretion (GO:0050796) | 2.31555878 |
| 118 | positive regulation of meiosis (GO:0045836) | 2.31350112 |
| 119 | respiratory electron transport chain (GO:0022904) | 2.30832752 |
| 120 | ER overload response (GO:0006983) | 2.30551884 |
| 121 | regulation of axon regeneration (GO:0048679) | 2.30287560 |
| 122 | regulation of neuron projection regeneration (GO:0070570) | 2.30287560 |
| 123 | positive regulation of vesicle fusion (GO:0031340) | 2.30181902 |
| 124 | peptide transport (GO:0015833) | 2.30160816 |
| 125 | detection of temperature stimulus (GO:0016048) | 2.29546837 |
| 126 | hormone transport (GO:0009914) | 2.29376732 |
| 127 | positive regulation of peptide secretion (GO:0002793) | 2.29309354 |
| 128 | electron transport chain (GO:0022900) | 2.28795808 |
| 129 | phenol-containing compound catabolic process (GO:0019336) | 2.28254114 |
| 130 | negative regulation of acute inflammatory response (GO:0002674) | 2.26942800 |
| 131 | retinol metabolic process (GO:0042572) | 2.26115650 |
| 132 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.24631675 |
| 133 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.24020007 |
| 134 | protein localization to cilium (GO:0061512) | 2.22983019 |
| 135 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.22927767 |
| 136 | aromatic amino acid family catabolic process (GO:0009074) | 2.22762230 |
| 137 | regulation of glutamate secretion (GO:0014048) | 2.22705185 |
| 138 | regulation of oxidative phosphorylation (GO:0002082) | 2.22587012 |
| 139 | serotonin receptor signaling pathway (GO:0007210) | 2.22388564 |
| 140 | regulation of neurotransmitter secretion (GO:0046928) | 2.22371485 |
| 141 | eosinophil chemotaxis (GO:0048245) | 2.21991193 |
| 142 | synaptic transmission, dopaminergic (GO:0001963) | 2.21702571 |
| 143 | vesicle transport along microtubule (GO:0047496) | 2.21691172 |
| 144 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.21411406 |
| 145 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.20630989 |
| 146 | mannosylation (GO:0097502) | 2.20583448 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.20129088 |
| 148 | protein maturation by protein folding (GO:0022417) | 2.19800391 |
| 149 | regulation of protein autophosphorylation (GO:0031952) | 2.19070663 |
| 150 | negative regulation of glucose import (GO:0046325) | 2.17767378 |
| 151 | type B pancreatic cell development (GO:0003323) | 2.16567763 |
| 152 | protein neddylation (GO:0045116) | 2.16030344 |
| 153 | neurotransmitter transport (GO:0006836) | 2.15919287 |
| 154 | iron ion transport (GO:0006826) | 2.14317696 |
| 155 | regulation of memory T cell differentiation (GO:0043380) | 2.13784907 |
| 156 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.13359893 |
| 157 | regulation of neurotransmitter transport (GO:0051588) | 2.12768140 |
| 158 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.12734584 |
| 159 | positive regulation of muscle hypertrophy (GO:0014742) | 2.12368991 |
| 160 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.12368991 |
| 161 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.12154890 |
| 162 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.11685873 |
| 163 | adenosine metabolic process (GO:0046085) | 2.11630583 |
| 164 | neuronal action potential (GO:0019228) | 2.11474067 |
| 165 | calcium ion-dependent exocytosis (GO:0017156) | 2.09879149 |
| 166 | cellular copper ion homeostasis (GO:0006878) | 2.09876085 |
| 167 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.09019395 |
| 168 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.09019395 |
| 169 | response to cocaine (GO:0042220) | 2.08804975 |
| 170 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.07290473 |
| 171 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.07198204 |
| 172 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.06949716 |
| 173 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.06226368 |
| 174 | transmission of nerve impulse (GO:0019226) | 2.06200740 |
| 175 | positive regulation of mitochondrial fission (GO:0090141) | 2.05534387 |
| 176 | synaptic transmission, glutamatergic (GO:0035249) | 2.04352917 |
| 177 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.03783587 |
| 178 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.02641206 |
| 179 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.02594348 |
| 180 | female mating behavior (GO:0060180) | 2.02468788 |
| 181 | cerebellar granule cell differentiation (GO:0021707) | 2.02084154 |
| 182 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.01655186 |
| 183 | regulation of dopamine secretion (GO:0014059) | 2.01634347 |
| 184 | substantia nigra development (GO:0021762) | 2.01534304 |
| 185 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.01126102 |
| 186 | synaptic vesicle transport (GO:0048489) | 2.01105546 |
| 187 | establishment of synaptic vesicle localization (GO:0097480) | 2.01105546 |
| 188 | locomotory exploration behavior (GO:0035641) | 2.00494925 |
| 189 | establishment of vesicle localization (GO:0051650) | 2.00191991 |
| 190 | nucleotide transmembrane transport (GO:1901679) | 1.99287033 |
| 191 | detection of calcium ion (GO:0005513) | 1.98818407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.93623274 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26231512 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54607426 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47407896 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.44957674 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.35760000 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.31558603 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15392760 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13269853 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08580385 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02591696 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99973137 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.97147823 |
| 14 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.93407235 |
| 15 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.93407235 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.91432843 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90630989 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89078777 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89078777 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88974227 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87849972 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86914245 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86521613 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84891111 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83547456 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83309325 |
| 27 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.81694418 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81578913 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.80786840 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76704946 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74284069 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73289441 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71227619 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67944447 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62343534 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61691764 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60847991 |
| 38 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60006941 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58169546 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57993028 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57627292 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57422699 |
| 43 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.55229894 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54759070 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54545876 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54001927 |
| 47 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.53956778 |
| 48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53003148 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50735671 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50660247 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48618042 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.47973938 |
| 53 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43670772 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43592512 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43146825 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40845992 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38568347 |
| 58 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.37836420 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37133052 |
| 60 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.36296899 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35380948 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35314901 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34350069 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34168505 |
| 65 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.31219465 |
| 66 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.29529439 |
| 67 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.27081576 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.26626959 |
| 69 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26330643 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26289247 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25739586 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25097610 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24124098 |
| 74 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22282443 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21856014 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21160173 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20821704 |
| 78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20722130 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19916482 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19858969 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18462866 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18100975 |
| 83 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.17489547 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17008396 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15223299 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14488283 |
| 87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14302624 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14072031 |
| 89 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13010797 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12904944 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12764395 |
| 92 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12194170 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11810663 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11177309 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10679796 |
| 96 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10375713 |
| 97 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10280669 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.09426071 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09089107 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09071044 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08892066 |
| 102 | JUN_21703547_ChIP-Seq_K562_Human | 1.08797721 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08037302 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07726473 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07197014 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06946630 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06865179 |
| 108 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06251645 |
| 109 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.04508116 |
| 110 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.03996005 |
| 111 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03751377 |
| 112 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03751377 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03689262 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03206140 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02402679 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01548921 |
| 117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01512961 |
| 118 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01512961 |
| 119 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01326549 |
| 120 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01168017 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00804933 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00441320 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99867148 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99503323 |
| 125 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99312564 |
| 126 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99312564 |
| 127 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98885195 |
| 128 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98854838 |
| 129 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98394298 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97792798 |
| 131 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97385572 |
| 132 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97155660 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96970379 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96374658 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95495397 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94550111 |
| 137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93804323 |
| 138 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93568922 |
| 139 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93527215 |
| 140 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92313788 |
| 141 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91602775 |
| 142 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90549157 |
| 143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90201575 |
| 144 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89443435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.50808464 |
| 2 | MP0004270_analgesia | 3.49679068 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.14378715 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.04869366 |
| 5 | MP0002735_abnormal_chemical_nociception | 2.82505878 |
| 6 | MP0002736_abnormal_nociception_after | 2.76961728 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.67611435 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 2.51264990 |
| 9 | MP0009745_abnormal_behavioral_response | 2.40767720 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.36876443 |
| 11 | MP0009046_muscle_twitch | 2.35096886 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.33361343 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.26315787 |
| 14 | MP0002064_seizures | 2.25991808 |
| 15 | MP0006054_spinal_hemorrhage | 2.11810752 |
| 16 | MP0002272_abnormal_nervous_system | 2.09897187 |
| 17 | MP0001944_abnormal_pancreas_morphology | 2.07174241 |
| 18 | MP0002693_abnormal_pancreas_physiology | 2.06721055 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.05197474 |
| 20 | MP0002822_catalepsy | 2.01387297 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.00575946 |
| 22 | MP0001970_abnormal_pain_threshold | 1.99817845 |
| 23 | MP0003283_abnormal_digestive_organ | 1.99117877 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.99078434 |
| 25 | MP0001984_abnormal_olfaction | 1.98427982 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.98385678 |
| 27 | MP0002063_abnormal_learning/memory/cond | 1.93581895 |
| 28 | MP0006072_abnormal_retinal_apoptosis | 1.92498188 |
| 29 | MP0001905_abnormal_dopamine_level | 1.89277758 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.89064893 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.84512521 |
| 32 | MP0003195_calcinosis | 1.79167932 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.73938424 |
| 34 | MP0005275_abnormal_skin_tensile | 1.67077327 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.66842553 |
| 36 | MP0001756_abnormal_urination | 1.65904645 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.64574218 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.62984276 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.59676425 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.58504769 |
| 41 | MP0005332_abnormal_amino_acid | 1.55759467 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.53922632 |
| 43 | MP0003329_amyloid_beta_deposits | 1.48099415 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.45074888 |
| 45 | MP0001486_abnormal_startle_reflex | 1.44732029 |
| 46 | MP0004858_abnormal_nervous_system | 1.42637636 |
| 47 | MP0005367_renal/urinary_system_phenotyp | 1.42359139 |
| 48 | MP0000516_abnormal_urinary_system | 1.42359139 |
| 49 | MP0001188_hyperpigmentation | 1.41144727 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.41081328 |
| 51 | MP0005171_absent_coat_pigmentation | 1.37634255 |
| 52 | MP0000920_abnormal_myelination | 1.35783139 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.31893728 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.28204761 |
| 55 | MP0004147_increased_porphyrin_level | 1.26998625 |
| 56 | MP0008877_abnormal_DNA_methylation | 1.25349151 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.25247352 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.24430403 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.23699998 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.22876530 |
| 61 | MP0004924_abnormal_behavior | 1.22529570 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.22529570 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.21968562 |
| 64 | MP0002102_abnormal_ear_morphology | 1.21415793 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.21218245 |
| 66 | MP0000372_irregular_coat_pigmentation | 1.21098943 |
| 67 | MP0001542_abnormal_bone_strength | 1.20800025 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.17873920 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.17643866 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.16649549 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.16244004 |
| 72 | MP0003633_abnormal_nervous_system | 1.15714679 |
| 73 | MP0005253_abnormal_eye_physiology | 1.15684285 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.14821380 |
| 75 | MP0002796_impaired_skin_barrier | 1.13404896 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 1.12658586 |
| 77 | MP0004510_myositis | 1.12163272 |
| 78 | MP0003075_altered_response_to | 1.11930402 |
| 79 | MP0008004_abnormal_stomach_pH | 1.11179826 |
| 80 | MP0003690_abnormal_glial_cell | 1.10521845 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 1.09680342 |
| 82 | MP0001765_abnormal_ion_homeostasis | 1.09616814 |
| 83 | MP0002928_abnormal_bile_duct | 1.09471355 |
| 84 | MP0000639_abnormal_adrenal_gland | 1.07713262 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 1.07385316 |
| 86 | MP0000538_abnormal_urinary_bladder | 1.06611404 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05721532 |
| 88 | MP0008569_lethality_at_weaning | 1.05350016 |
| 89 | MP0001529_abnormal_vocalization | 1.04853008 |
| 90 | MP0001177_atelectasis | 1.04666634 |
| 91 | MP0002184_abnormal_innervation | 1.04493812 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 1.03421489 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 1.03137331 |
| 94 | MP0004142_abnormal_muscle_tone | 1.02723519 |
| 95 | MP0005535_abnormal_body_temperature | 1.01897887 |
| 96 | MP0003186_abnormal_redox_activity | 1.00283707 |
| 97 | MP0001661_extended_life_span | 1.00229589 |
| 98 | MP0005165_increased_susceptibility_to | 1.00136609 |
| 99 | MP0003252_abnormal_bile_duct | 0.99650806 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.96700197 |
| 101 | MP0000604_amyloidosis | 0.96464884 |
| 102 | MP0003787_abnormal_imprinting | 0.96167939 |
| 103 | MP0003879_abnormal_hair_cell | 0.94749285 |
| 104 | MP0002254_reproductive_system_inflammat | 0.94492085 |
| 105 | MP0005448_abnormal_energy_balance | 0.94319924 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.93498075 |
| 107 | MP0002938_white_spotting | 0.93202151 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.93063172 |
| 109 | MP0003631_nervous_system_phenotype | 0.91975494 |
| 110 | MP0004043_abnormal_pH_regulation | 0.91542408 |
| 111 | MP0003806_abnormal_nucleotide_metabolis | 0.91510267 |
| 112 | MP0000778_abnormal_nervous_system | 0.90129705 |
| 113 | MP0002066_abnormal_motor_capabilities/c | 0.89452408 |
| 114 | MP0008874_decreased_physiological_sensi | 0.89378457 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.89321366 |
| 116 | MP0009840_abnormal_foam_cell | 0.89153226 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.89152729 |
| 118 | MP0003634_abnormal_glial_cell | 0.89078471 |
| 119 | MP0003953_abnormal_hormone_level | 0.88740465 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.88722826 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.88598688 |
| 122 | MP0002090_abnormal_vision | 0.88191411 |
| 123 | MP0003045_fibrosis | 0.88091877 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.87021354 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.85928212 |
| 126 | MP0004811_abnormal_neuron_physiology | 0.85906159 |
| 127 | MP0000955_abnormal_spinal_cord | 0.85582655 |
| 128 | MP0002006_tumorigenesis | 0.82282639 |
| 129 | MP0005503_abnormal_tendon_morphology | 0.82271509 |
| 130 | MP0006036_abnormal_mitochondrial_physio | 0.81899793 |
| 131 | MP0004742_abnormal_vestibular_system | 0.81295440 |
| 132 | MP0002882_abnormal_neuron_morphology | 0.81190830 |
| 133 | MP0003868_abnormal_feces_composition | 0.80791540 |
| 134 | MP0005164_abnormal_response_to | 0.80670980 |
| 135 | MP0001664_abnormal_digestion | 0.79971618 |
| 136 | MP0004484_altered_response_of | 0.79731117 |
| 137 | MP0002009_preneoplasia | 0.79678300 |
| 138 | MP0004272_abnormal_basement_membrane | 0.79546862 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.78803757 |
| 140 | MP0005365_abnormal_bile_salt | 0.78550220 |
| 141 | MP0002163_abnormal_gland_morphology | 0.78515811 |
| 142 | MP0005058_abnormal_lysosome_morphology | 0.78465983 |
| 143 | MP0003011_delayed_dark_adaptation | 0.78459961 |
| 144 | MP0002229_neurodegeneration | 0.78121070 |
| 145 | MP0010771_integument_phenotype | 0.78012711 |
| 146 | MP0000427_abnormal_hair_cycle | 0.76343874 |
| 147 | MP0002168_other_aberrant_phenotype | 0.75540987 |
| 148 | MP0004036_abnormal_muscle_relaxation | 0.72967055 |
| 149 | MP0005084_abnormal_gallbladder_morpholo | 0.69625023 |
| 150 | MP0008872_abnormal_physiological_respon | 0.68987998 |
| 151 | MP0004883_abnormal_blood_vessel | 0.68898747 |
| 152 | MP0004885_abnormal_endolymph | 0.68645784 |
| 153 | MP0001502_abnormal_circadian_rhythm | 0.67913983 |
| 154 | MP0001963_abnormal_hearing_physiology | 0.67418370 |
| 155 | MP0005623_abnormal_meninges_morphology | 0.66379825 |
| 156 | MP0004130_abnormal_muscle_cell | 0.65040557 |
| 157 | MP0004134_abnormal_chest_morphology | 0.63852507 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.63593327 |
| 159 | MP0005595_abnormal_vascular_smooth | 0.63297682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.78779798 |
| 2 | Atonic seizures (HP:0010819) | 4.42733077 |
| 3 | Myokymia (HP:0002411) | 4.14245337 |
| 4 | Hypothermia (HP:0002045) | 4.05227972 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.01661139 |
| 6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.73286034 |
| 7 | Ketoacidosis (HP:0001993) | 3.72642842 |
| 8 | Large for gestational age (HP:0001520) | 3.71492547 |
| 9 | Pheochromocytoma (HP:0002666) | 3.71311447 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.68450876 |
| 11 | Neuroendocrine neoplasm (HP:0100634) | 3.66324520 |
| 12 | Hyperglycemia (HP:0003074) | 3.56079378 |
| 13 | Vascular calcification (HP:0004934) | 3.53884559 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.40465364 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.38502905 |
| 16 | Cardiovascular calcification (HP:0011915) | 3.34212149 |
| 17 | Progressive macrocephaly (HP:0004481) | 3.16995660 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.11444767 |
| 19 | Febrile seizures (HP:0002373) | 2.97224155 |
| 20 | Focal seizures (HP:0007359) | 2.94709201 |
| 21 | Absence seizures (HP:0002121) | 2.89024787 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.88020177 |
| 23 | Sensory axonal neuropathy (HP:0003390) | 2.87371624 |
| 24 | Insidious onset (HP:0003587) | 2.85719072 |
| 25 | Termporal pattern (HP:0011008) | 2.85719072 |
| 26 | Tongue fasciculations (HP:0001308) | 2.83857755 |
| 27 | Mitochondrial inheritance (HP:0001427) | 2.81987819 |
| 28 | Epileptic encephalopathy (HP:0200134) | 2.81897036 |
| 29 | Abnormality of vitamin B metabolism (HP:0004340) | 2.80078624 |
| 30 | Acute encephalopathy (HP:0006846) | 2.78366406 |
| 31 | Metaphyseal dysplasia (HP:0100255) | 2.77129646 |
| 32 | Renal cortical cysts (HP:0000803) | 2.70307035 |
| 33 | Ulnar claw (HP:0001178) | 2.69339743 |
| 34 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.68835506 |
| 35 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.68835506 |
| 36 | Hyperventilation (HP:0002883) | 2.67109164 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 2.62577986 |
| 38 | Dialeptic seizures (HP:0011146) | 2.57968029 |
| 39 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.57831918 |
| 40 | Stomatitis (HP:0010280) | 2.55303284 |
| 41 | Thyroiditis (HP:0100646) | 2.54392058 |
| 42 | Abnormality of the renal cortex (HP:0011035) | 2.53487490 |
| 43 | Autoamputation (HP:0001218) | 2.53453969 |
| 44 | Hematochezia (HP:0002573) | 2.52792774 |
| 45 | Action tremor (HP:0002345) | 2.45978366 |
| 46 | Generalized tonic-clonic seizures (HP:0002069) | 2.45881460 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.43476514 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.43476514 |
| 49 | Visual hallucinations (HP:0002367) | 2.43199343 |
| 50 | Ketosis (HP:0001946) | 2.43089163 |
| 51 | Increased CSF protein (HP:0002922) | 2.41883558 |
| 52 | Albinism (HP:0001022) | 2.40888122 |
| 53 | Increased CSF lactate (HP:0002490) | 2.39943313 |
| 54 | Increased serum pyruvate (HP:0003542) | 2.38987293 |
| 55 | Abnormality of glycolysis (HP:0004366) | 2.38987293 |
| 56 | Cerebral hemorrhage (HP:0001342) | 2.38970236 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.36247496 |
| 58 | Parakeratosis (HP:0001036) | 2.35249647 |
| 59 | Hemiparesis (HP:0001269) | 2.35023355 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.30755092 |
| 61 | Abnormality of vitamin metabolism (HP:0100508) | 2.29737161 |
| 62 | Muscle fibrillation (HP:0010546) | 2.27113837 |
| 63 | Medial flaring of the eyebrow (HP:0010747) | 2.26798267 |
| 64 | Agitation (HP:0000713) | 2.26433275 |
| 65 | Symptomatic seizures (HP:0011145) | 2.25616628 |
| 66 | Intestinal atresia (HP:0011100) | 2.22912760 |
| 67 | Enlarged penis (HP:0000040) | 2.22876299 |
| 68 | Gait imbalance (HP:0002141) | 2.21429147 |
| 69 | Neurofibrillary tangles (HP:0002185) | 2.20327686 |
| 70 | Hepatocellular necrosis (HP:0001404) | 2.19717242 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.19086003 |
| 72 | Progressive inability to walk (HP:0002505) | 2.18539721 |
| 73 | Methylmalonic aciduria (HP:0012120) | 2.17248330 |
| 74 | Congenital primary aphakia (HP:0007707) | 2.16778690 |
| 75 | Proximal tubulopathy (HP:0000114) | 2.13776257 |
| 76 | Genital tract atresia (HP:0001827) | 2.13129234 |
| 77 | Abnormality of the corticospinal tract (HP:0002492) | 2.12397151 |
| 78 | Late onset (HP:0003584) | 2.12277608 |
| 79 | Anxiety (HP:0000739) | 2.12244743 |
| 80 | Epileptiform EEG discharges (HP:0011182) | 2.11534633 |
| 81 | Palpitations (HP:0001962) | 2.10305444 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.10071529 |
| 83 | 3-Methylglutaconic aciduria (HP:0003535) | 2.09618467 |
| 84 | Vaginal atresia (HP:0000148) | 2.09057340 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.08866971 |
| 86 | Hypomagnesemia (HP:0002917) | 2.07815053 |
| 87 | Limb dystonia (HP:0002451) | 2.07804201 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.07683210 |
| 89 | Bone cyst (HP:0012062) | 2.07134756 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 2.04326749 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03227748 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03227748 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03227748 |
| 94 | Patchy hypopigmentation of hair (HP:0011365) | 2.03116838 |
| 95 | Scanning speech (HP:0002168) | 2.01803905 |
| 96 | Renal Fanconi syndrome (HP:0001994) | 2.00307113 |
| 97 | Conjunctival hamartoma (HP:0100780) | 1.99688809 |
| 98 | X-linked dominant inheritance (HP:0001423) | 1.99407153 |
| 99 | Retinal dysplasia (HP:0007973) | 1.98385731 |
| 100 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98343934 |
| 101 | Cutaneous melanoma (HP:0012056) | 1.97526481 |
| 102 | Abnormal hair whorl (HP:0010721) | 1.96547854 |
| 103 | Testicular neoplasm (HP:0010788) | 1.93207623 |
| 104 | Abnormal eating behavior (HP:0100738) | 1.90470166 |
| 105 | Hamartoma of the eye (HP:0010568) | 1.90122559 |
| 106 | Petechiae (HP:0000967) | 1.89937847 |
| 107 | Arthropathy (HP:0003040) | 1.89895584 |
| 108 | Hypokinesia (HP:0002375) | 1.89880254 |
| 109 | Increased hepatocellular lipid droplets (HP:0006565) | 1.88051344 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.87511346 |
| 111 | Hypoplasia of the fovea (HP:0007750) | 1.87511346 |
| 112 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.86830495 |
| 113 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86739023 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86564616 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86564616 |
| 116 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86564616 |
| 117 | Mucopolysacchariduria (HP:0008155) | 1.86364034 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86364034 |
| 119 | Abnormality of renal resorption (HP:0011038) | 1.85939151 |
| 120 | Hypoproteinemia (HP:0003075) | 1.85841803 |
| 121 | Cerebral edema (HP:0002181) | 1.85593442 |
| 122 | Hepatic necrosis (HP:0002605) | 1.85056339 |
| 123 | Hypsarrhythmia (HP:0002521) | 1.84971228 |
| 124 | Oligomenorrhea (HP:0000876) | 1.84939462 |
| 125 | Supranuclear gaze palsy (HP:0000605) | 1.84891759 |
| 126 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84433587 |
| 127 | Furrowed tongue (HP:0000221) | 1.83719758 |
| 128 | Glycosuria (HP:0003076) | 1.81837952 |
| 129 | Abnormality of urine glucose concentration (HP:0011016) | 1.81837952 |
| 130 | Amblyopia (HP:0000646) | 1.81660045 |
| 131 | Glucose intolerance (HP:0000833) | 1.80423663 |
| 132 | Leukodystrophy (HP:0002415) | 1.80040142 |
| 133 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79926986 |
| 134 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79926986 |
| 135 | Aplasia involving bones of the extremities (HP:0009825) | 1.79926986 |
| 136 | Truncal ataxia (HP:0002078) | 1.77062733 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 1.76636065 |
| 138 | Abnormal pancreas size (HP:0012094) | 1.76616386 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.76258238 |
| 140 | Bradycardia (HP:0001662) | 1.75926563 |
| 141 | Mutism (HP:0002300) | 1.74502255 |
| 142 | Hypoalbuminemia (HP:0003073) | 1.74302973 |
| 143 | Abnormal albumin level (HP:0012116) | 1.74302973 |
| 144 | Congenital stationary night blindness (HP:0007642) | 1.74248330 |
| 145 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73933241 |
| 146 | Onycholysis (HP:0001806) | 1.73902275 |
| 147 | Myotonia (HP:0002486) | 1.73611023 |
| 148 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73433050 |
| 149 | Peripheral hypomyelination (HP:0007182) | 1.73229699 |
| 150 | Hyperphosphatemia (HP:0002905) | 1.73068214 |
| 151 | Akinesia (HP:0002304) | 1.71659400 |
| 152 | Postural tremor (HP:0002174) | 1.71634429 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.71598387 |
| 154 | Absent speech (HP:0001344) | 1.69464542 |
| 155 | Diminished movement (HP:0002374) | 1.69155938 |
| 156 | White forelock (HP:0002211) | 1.68591106 |
| 157 | Blue irides (HP:0000635) | 1.68546077 |
| 158 | Hypoventilation (HP:0002791) | 1.68276643 |
| 159 | Abnormality of the vocal cords (HP:0008777) | 1.67603036 |
| 160 | Abnormal gallbladder physiology (HP:0012438) | 1.66998122 |
| 161 | Cholecystitis (HP:0001082) | 1.66998122 |
| 162 | Lactic acidosis (HP:0003128) | 1.65991929 |
| 163 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.65763970 |
| 164 | Methylmalonic acidemia (HP:0002912) | 1.64417572 |
| 165 | Respiratory failure (HP:0002878) | 1.64088190 |
| 166 | Optic disc pallor (HP:0000543) | 1.64025371 |
| 167 | Generalized myoclonic seizures (HP:0002123) | 1.63784798 |
| 168 | Lipid accumulation in hepatocytes (HP:0006561) | 1.63755844 |
| 169 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.63673961 |
| 170 | Dysmetria (HP:0001310) | 1.63387009 |
| 171 | Delayed gross motor development (HP:0002194) | 1.63124291 |
| 172 | Torticollis (HP:0000473) | 1.62469267 |
| 173 | Ankle clonus (HP:0011448) | 1.62083275 |
| 174 | Failure to thrive in infancy (HP:0001531) | 1.61743718 |
| 175 | Poor suck (HP:0002033) | 1.61395361 |
| 176 | Polyphagia (HP:0002591) | 1.60796427 |
| 177 | Impaired pain sensation (HP:0007328) | 1.60694560 |
| 178 | Abnormality of pain sensation (HP:0010832) | 1.60694560 |
| 179 | Increased intramyocellular lipid droplets (HP:0012240) | 1.58998955 |
| 180 | Steppage gait (HP:0003376) | 1.57667955 |
| 181 | Hyperthyroidism (HP:0000836) | 1.55548082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.77224748 |
| 2 | MAP3K12 | 3.68867492 |
| 3 | MAP4K2 | 2.88820543 |
| 4 | NTRK3 | 2.39842215 |
| 5 | NTRK1 | 2.38360807 |
| 6 | MST4 | 2.32659406 |
| 7 | MAP2K7 | 2.28651592 |
| 8 | STK39 | 2.12263490 |
| 9 | OXSR1 | 2.11997923 |
| 10 | ARAF | 2.11934134 |
| 11 | GRK5 | 2.03695874 |
| 12 | MAP3K2 | 1.99622721 |
| 13 | TAOK3 | 1.93736802 |
| 14 | MINK1 | 1.90804791 |
| 15 | MAP3K4 | 1.89790732 |
| 16 | PLK2 | 1.88601977 |
| 17 | GRK1 | 1.87842978 |
| 18 | FRK | 1.86020779 |
| 19 | PHKG1 | 1.80302833 |
| 20 | RIPK4 | 1.80065072 |
| 21 | BMPR1B | 1.73807307 |
| 22 | BCR | 1.72296313 |
| 23 | TESK1 | 1.69703048 |
| 24 | ACVR1B | 1.64053546 |
| 25 | EPHA4 | 1.63554459 |
| 26 | MAP2K4 | 1.62834770 |
| 27 | MAPKAPK5 | 1.57836291 |
| 28 | FER | 1.54812454 |
| 29 | LIMK1 | 1.48707667 |
| 30 | FGFR3 | 1.48448981 |
| 31 | CDK19 | 1.47680642 |
| 32 | CAMKK2 | 1.47203077 |
| 33 | IRAK3 | 1.47152666 |
| 34 | SIK3 | 1.33574360 |
| 35 | MAP3K9 | 1.32370573 |
| 36 | DAPK2 | 1.31691997 |
| 37 | BMPR2 | 1.31628449 |
| 38 | TRIM28 | 1.30418252 |
| 39 | PRKCE | 1.26494396 |
| 40 | TNIK | 1.23033305 |
| 41 | MYLK | 1.21601807 |
| 42 | GRK7 | 1.19645375 |
| 43 | STK3 | 1.15730978 |
| 44 | SGK494 | 1.15285218 |
| 45 | SGK223 | 1.15285218 |
| 46 | WNK3 | 1.14861141 |
| 47 | PRPF4B | 1.12760133 |
| 48 | EIF2AK3 | 1.12084591 |
| 49 | NLK | 1.10758823 |
| 50 | KSR2 | 1.09843941 |
| 51 | WNK4 | 1.09693358 |
| 52 | PRKD3 | 1.08708733 |
| 53 | STK38L | 1.08488369 |
| 54 | MAP2K1 | 1.07793573 |
| 55 | PTK2B | 1.05033309 |
| 56 | MUSK | 1.02802569 |
| 57 | MAPK13 | 1.01470245 |
| 58 | CAMK2A | 0.97681511 |
| 59 | ADRBK2 | 0.96731123 |
| 60 | PDK2 | 0.96680200 |
| 61 | ERBB3 | 0.94215767 |
| 62 | SGK2 | 0.91506738 |
| 63 | CDK5 | 0.90961279 |
| 64 | CSNK1G2 | 0.89982592 |
| 65 | PAK3 | 0.87236115 |
| 66 | PRKCG | 0.83243396 |
| 67 | TRPM7 | 0.81808721 |
| 68 | AKT3 | 0.80198438 |
| 69 | PDK4 | 0.79978126 |
| 70 | PDK3 | 0.79978126 |
| 71 | LMTK2 | 0.79751467 |
| 72 | CSNK1G3 | 0.78915597 |
| 73 | CAMK2D | 0.78893567 |
| 74 | NME1 | 0.78530481 |
| 75 | MAP2K6 | 0.77753259 |
| 76 | CAMK2B | 0.77350530 |
| 77 | MST1R | 0.76451703 |
| 78 | MAP3K3 | 0.76075379 |
| 79 | INSRR | 0.75604547 |
| 80 | NUAK1 | 0.74084038 |
| 81 | PIK3CA | 0.73040619 |
| 82 | ADRBK1 | 0.72661099 |
| 83 | RET | 0.70941736 |
| 84 | MAP3K1 | 0.69933272 |
| 85 | CAMK2G | 0.69635643 |
| 86 | STK38 | 0.69471787 |
| 87 | ERBB4 | 0.66843849 |
| 88 | WNK1 | 0.66288673 |
| 89 | NEK6 | 0.64938310 |
| 90 | PBK | 0.64631895 |
| 91 | DAPK1 | 0.64083016 |
| 92 | PIM2 | 0.62626406 |
| 93 | CAMKK1 | 0.62137271 |
| 94 | PRKCH | 0.61907231 |
| 95 | MAPKAPK3 | 0.61621807 |
| 96 | IKBKB | 0.61432466 |
| 97 | JAK1 | 0.59494058 |
| 98 | STK24 | 0.58528810 |
| 99 | MATK | 0.58214542 |
| 100 | MET | 0.57101805 |
| 101 | TXK | 0.56937791 |
| 102 | EIF2AK1 | 0.56912024 |
| 103 | PLK3 | 0.56766714 |
| 104 | ROCK2 | 0.56030449 |
| 105 | PINK1 | 0.54842626 |
| 106 | HIPK2 | 0.53812173 |
| 107 | CSNK1G1 | 0.51205481 |
| 108 | PDPK1 | 0.49858368 |
| 109 | ILK | 0.49723162 |
| 110 | FGFR2 | 0.48822883 |
| 111 | EPHB2 | 0.48774282 |
| 112 | CDK14 | 0.48321714 |
| 113 | PAK6 | 0.47965174 |
| 114 | PASK | 0.47570856 |
| 115 | CSNK1A1L | 0.47332912 |
| 116 | TNK2 | 0.46756291 |
| 117 | PTK2 | 0.46162916 |
| 118 | SGK3 | 0.44118796 |
| 119 | GSK3A | 0.44098104 |
| 120 | FGR | 0.44097956 |
| 121 | TGFBR2 | 0.43934828 |
| 122 | FES | 0.42416152 |
| 123 | DDR2 | 0.42288575 |
| 124 | PRKACA | 0.42076612 |
| 125 | MOS | 0.40641857 |
| 126 | MAP3K14 | 0.40639603 |
| 127 | ABL2 | 0.40449060 |
| 128 | ROCK1 | 0.40251367 |
| 129 | EPHA3 | 0.39906498 |
| 130 | EPHB1 | 0.39660414 |
| 131 | PRKCQ | 0.38818256 |
| 132 | PHKG2 | 0.37299054 |
| 133 | PRKAA2 | 0.36589806 |
| 134 | NEK1 | 0.36102472 |
| 135 | PRKCI | 0.35182611 |
| 136 | TEC | 0.34667482 |
| 137 | PRKG1 | 0.33429322 |
| 138 | PRKCA | 0.33034035 |
| 139 | MKNK2 | 0.32623095 |
| 140 | DAPK3 | 0.30007959 |
| 141 | PIK3CG | 0.29421233 |
| 142 | SCYL2 | 0.26454196 |
| 143 | IKBKE | 0.26360880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.18488895 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.37108148 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.08962967 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76122314 |
| 5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.29830932 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 1.94422451 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 1.89413887 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.88785406 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 1.82918243 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.77860691 |
| 11 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.73025662 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69399172 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.66343151 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.66055358 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.65534812 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64163959 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55900590 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55176703 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54828341 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54042386 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.50496890 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.49485358 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47759598 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46029333 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45192237 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.44459953 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44443512 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.44277832 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.38805282 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.34801644 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33177470 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32204793 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31583611 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.31204882 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29769095 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.29316567 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.26646361 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.25274333 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24368829 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20525351 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14806011 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.13992167 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13292570 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.12337235 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09638744 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09411719 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09388922 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08895090 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05966714 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00684514 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.99068721 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97874287 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97552353 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96860295 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91787284 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90429682 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89622558 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88677896 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88225583 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86074453 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84732824 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84187481 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83351711 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82556313 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81466411 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80111285 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78115509 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77807014 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77166085 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76841798 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76645180 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76618554 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76553056 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76375650 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75092483 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74853915 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74840357 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74437380 |
| 79 | Proteasome_Homo sapiens_hsa03050 | 0.72133349 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70031916 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69414756 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.67922879 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67495966 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.66523658 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65187309 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63941374 |
| 87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63117964 |
| 88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62466318 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61540762 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61486636 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.60969181 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59753278 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59196520 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57366539 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57011832 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55976586 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55758587 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55220311 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53544967 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53376227 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52705732 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51451521 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51377769 |
| 104 | Phototransduction_Homo sapiens_hsa04744 | 0.51194414 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50654681 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49940642 |
| 107 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49842115 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49101102 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49019175 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48691902 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48672582 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.48250564 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47142841 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46858674 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46548093 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.45233333 |
| 117 | Melanoma_Homo sapiens_hsa05218 | 0.45167206 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44616693 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44216851 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43823878 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.43774016 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43678381 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.43085861 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42913737 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41926434 |
| 126 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41324613 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40831950 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.40773673 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40616190 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40243892 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39815797 |
| 132 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39430584 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.37582519 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37246155 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35884251 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.35103581 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35054174 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.33877999 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31405729 |
| 140 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.30851182 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.30219600 |

